Dr Reddy's Launches Cancer Drug Abiraterone Acetate In US Market

Business Standard

The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson

Topics

Dr Reddy's Laboratories Limited | cancer drug | Dr Reddy’s cancer drug

BS Reporter  |  Hyderabad 

Dr Reddy's

The drug, which is used in cancer treatment, is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson.

Dr Reddy's Laboratories Limited today announced the launch of Abiraterone Acetate Tablets in the US market, following approval from the US Food and Drug Administration (USFDA).

The drug, which is used in cancer treatment, is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson.

Abiraterone Acetate is a significant launch for the company, as the Zytiga brand and generic market had US sales of approximately $454 million for the most recent twelve months ending in March 2020 according to IQVIA Health.

First Published: Fri, June 19 2020. 15:30 IST

';if(neverShowNotificaitonCookie==''||neverShowNotificaitonCookie=='undefined'||neverShowNotificaitonCookie==null){var lastReminderCookie=getCookie('_ler'+loginParamObj.uId);if((lastReminderCookie=="")||(lastReminderCookie=="undefined")||(lastReminderCookie==null)){$('body').prepend(notificationBox);}else{if(lastReminderCookie

RECENT NEWS

Titi Coles Legacy In Finance: Pioneering Diversity And Leadership

Titi Cole, one of the most senior Black women in the world of finance, recently exited her high-profile role at Citi. He... Read more

Rising Rates, Rising Challenges: Bankers Adapt To Serve Troubled Companies In A Changing Economic Landscape

As interest rates climb, troubled companies are facing heightened financial pressures, prompting them to seek assistance... Read more

The Elusive Nature Of Fraud Detection: Exploring The Auditor's Dilemma

In the intricate world of financial reporting, auditors serve as guardians of integrity, tasked with uncovering discrepa... Read more

The Battle For Depositors: US Lenders Ramp Up Efforts Amidst Rate Uncertainty

In the competitive landscape of the US banking sector, retaining depositors is paramount for lenders seeking to maintain... Read more

Beyond Capital: Unveiling The Complexities Of Bank Failure Prediction

In the realm of banking, the ability to predict and prevent failures is paramount for financial stability and consumer c... Read more

Central Banks And The Economic Horizon: Steering Through Uncertaintie

In the evolving landscape of global financial markets, the strategic role of central banks has come under intense scruti... Read more